Exposure-Based Treatment for Perfectionism for Perfectionism

Phase-Based Progress Estimates
Florida State University, Department of Psychology, Tallahassee, FL
Exposure-Based Treatment for Perfectionism - Behavioral
All Sexes
What conditions do you have?

Study Summary

This study is examining the efficacy of a computerized, exposure-based, intervention for perfectionism.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: Change in depression symptoms from baseline to post treatment (2 weeks) and from baseline to follow-up (6 weeks)

Week 6
Center for Epidemiological Studies Depression Scale (CES-D)
Week 6
Week 6
State-Trait Inventory for Cognitive and Somatic Anxiety-Trait Version (STICSA-T)
Week 6
Frost Multidimensional Perfectionism Scale (FMPS)- Concern Over Mistakes Subscale
Week 6
Irrational Procrastination Scale
Week 6
Social Phobia inventory (SPIN)

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Stress Management Condition
1 of 2
Exposure-Based Treatment for Perfectionism
1 of 2
Active Control
Experimental Treatment

82 Total Participants · 2 Treatment Groups

Primary Treatment: Exposure-Based Treatment for Perfectionism · No Placebo Group · N/A

Exposure-Based Treatment for Perfectionism
Experimental Group · 1 Intervention: Exposure-Based Treatment for Perfectionism · Intervention Types: Behavioral
Stress Management Condition
ActiveComparator Group · 1 Intervention: Stress Management · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change in depression symptoms from baseline to post treatment (2 weeks) and from baseline to follow-up (6 weeks)

Trial Background

Prof. Jesse Cougle, Professor of Psychology
Principal Investigator
Florida State University
Closest Location: Florida State University, Department of Psychology · Tallahassee, FL
2016First Recorded Clinical Trial
2 TrialsResearching Perfectionism
6 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.